COMP <GO>
FRNM vs CSTL // EV/EBITDA & P/E VALUATION
Freenome Inc. (NASDAQ) VS. Castle Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: FRNM 2
— CSTL 3
■ METRIC PARITY
LAST: $12.86 (-4.32%) • MKT CAP: $1.38B
valuation
—
LAST: $38.51 (+4.99%) • MKT CAP: $1.18B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FRNM VS. CSTL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FRNM | CSTL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 79.40% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -3.40% | -9.30% | +5.90 | FRNM | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.06% | 2.41% | -2.47 | CSTL | /fcf-yield <GO> |
| Operating Margin | — | -12.40% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -7.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 3.70% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 6.97 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 6/9 | -5.00 | CSTL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.9 | 60.9 | -20.95 | CSTL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.38B | $1.18B | $205.3M | FRNM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FRNM REV | CSTL REV | FRNM GROSS % | CSTL GROSS % | FRNM FCF | CSTL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $344.2M | — | 79.4% | -$864.7K | $28.3M |
| FY 2024 | $0 | $332.1M | — | 81.9% | — | $36.5M |
| FY 2023 | — | $219.8M | — | — | — | -$5.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FRNM // BETA —
CSTL // BETA —